All News

December 27, 2023

Texas Spine Consultants Partners with United Musculoskeletal Partners

December 26, 2023

AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases

December 26, 2023

Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio

December 26, 2023

Immunome to Acquire Antibody-Related Assets and Materials from Atreca

December 22, 2023

Amylyx Pharmaceuticals Announces First Participant Dosed in the Global Phase 3 ORION Study of AMX0035 in Progressive Supranuclear Palsy (PSP)

December 22, 2023

PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion

December 22, 2023

AECOM selected as delivery partner for Eglinton Crosstown West Extension in Toronto

December 21, 2023

RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer

December 21, 2023

Cardiovascular Advanced Practice Provider (APP) Compensation and APP to Physician Ratio Show Steady Increase

December 21, 2023

Luna Announces $50 Million Strategic Investment from White Hat Capital Partners

December 20, 2023

Hatch BioFund Announces New Partnership with Brandywine Realty Trust

December 20, 2023

Integrated Biosciences Announces Nature Publication Identifying New Class of Antibiotics Discovered Via Company’s AI-Powered Platform

Business & Leadership